QUEENNo-Touch Saphenous Vein vs. Radial Artery in Women's Coronary Bypass
This study aims to compare the effectiveness of no-touch saphenous vein grafts with radial artery grafts in women undergoing coronary bypass surgery by observing graft occlusion rates.
Coronary artery bypass graft
Cardiovascular Diseases+2
+ Coronary Disease
+ Heart Diseases
Treatment Study
Summary
Study start date: January 1, 2024
Actual date on which the first participant was enrolled.This study explores two different methods for obtaining blood vessels for heart surgery, specifically in women requiring coronary artery bypass grafting. The focus is on comparing the long-term effectiveness of using a saphenous vein with a special technique called "no-touch" against using a radial artery. The aim is to determine which method provides a better and longer-lasting graft for the second-best coronary artery after the main artery has been treated. This is important because it could improve surgical results and long-term heart health for women undergoing this type of surgery. Participants in this study will undergo coronary artery bypass grafting, where surgeons will use either the no-touch technique on the saphenous vein or the radial artery for the grafting process. The effectiveness of each method will be evaluated by checking how well these grafts remain open and functional over time. This is measured through follow-up assessments after the surgery to ensure the selected technique provides the best possible outcome for the patients. The study aims to provide more evidence to help doctors decide the best approach for women needing this procedure.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.150 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Female
Biological sex of participants that are eligible to enroll.From 18 to 75 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
Group II
Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina de São Paulo
São Paulo, BrazilOpen Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina de São Paulo in Google Maps